Samuel Benchimol focuses on Gene, Cell biology, Molecular biology, Cancer research and Gene expression. His Gene research incorporates elements of Radioresistance and Cell type. The study incorporates disciplines such as Apoptosis, Regulation of gene expression and Intrinsic apoptosis in addition to Cell biology.
The Molecular biology study combines topics in areas such as RNA, DNA damage, Telomerase reverse transcriptase and DNA replication. His research in Cancer research intersects with topics in Cell cycle checkpoint, Cell culture, Transfection, Carcinogenesis and Psychological repression. His research investigates the connection with Gene expression and areas like Gene rearrangement which intersect with concerns in Murine leukemia virus, Oncovirus, Oncogene, Friend virus and Friend leukemia.
His scientific interests lie mostly in Molecular biology, Gene, Cancer research, Cell biology and DNA damage. His biological study spans a wide range of topics, including Cell culture, Transfection, Mutation, Mutant and DNA. His research on Gene concerns the broader Genetics.
As a part of the same scientific family, Samuel Benchimol mostly works in the field of Cancer research, focusing on Tumor suppressor gene and, on occasion, Carcinoma. His work deals with themes such as Apoptosis, Cell cycle, Ubiquitin and Immunoprecipitation, which intersect with Cell biology. His DNA damage study incorporates themes from Radiosensitivity, Transcription factor, Mitosis, DNA repair and Telomere.
Samuel Benchimol spends much of his time researching Cell biology, DNA damage, Cancer research, Ubiquitin and Cancer. His Cell biology study combines topics in areas such as Telomere and Genetics. He interconnects Cell cycle checkpoint, Receptor, In Situ Nick-End Labeling, Caspase 2 and Gene targeting in the investigation of issues within DNA damage.
His Cancer research study combines topics from a wide range of disciplines, such as Transcription factor, Programmed cell death, DNA repair and Morpholino. His Ubiquitin research includes elements of Molecular biology, Proto-Oncogene Proteins c-mdm2, Subcellular localization and Promoter. He performs multidisciplinary study on Molecular biology and HIV Long Terminal Repeat in his works.
Samuel Benchimol mainly focuses on DNA damage, Adipocyte, Oral and maxillofacial pathology, Carcinoma and Mouth neoplasm. His DNA damage research includes themes of Suppressor, HEK 293 cells, Molecular biology, Proto-Oncogene Proteins c-myc and Ubiquitin ligase. His study in Adipocyte intersects with areas of studies such as Metabolism, C2C12, Lipid metabolism, Phosphorylation and Biochemistry.
His Metabolism study often links to related topics such as Enzyme activator. His Oral and maxillofacial pathology study overlaps with Cancer registry, Pathology, Dysplasia, Epithelial dysplasia and DNA Image Cytometry. His research on Carcinoma often connects related areas such as Cancer.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span
Homayoun Vaziri;Samuel Benchimol.
Current Biology (1998)
Regulation of PTEN transcription by p53.
V. Stambolic;D. MacPherson;D. Sas;Y. Lin.
Molecular Cell (2001)
p53: oncogene or anti-oncogene?
David P. Lane;Sam Benchimol.
Genes & Development (1990)
Pirh2, a p53-Induced Ubiquitin-Protein Ligase, Promotes p53 Degradation
Roger P. Leng;Yunping Lin;Weili Ma;Hong Wu.
Cell (2003)
ATM‐dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post‐translational activation of p53 protein involving poly(ADP‐ribose) polymerase
Homayoun Vaziri;Michael D. West;Richard C. Allsopp;Timothy S. Davison.
The EMBO Journal (1997)
Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus
Michael Mowat;Michael Mowat;Ambrose Cheng;Ambrose Cheng;Nobuhiro Kimura;Nobuhiro Kimura;Alan Bernstein;Alan Bernstein.
Nature (1985)
Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis.
Yunping Lin;Weili Ma;Samuel Benchimol.
Nature Genetics (2000)
Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia
H Ahuja;M Bar-Eli;S H Advani;S Benchimol.
Proceedings of the National Academy of Sciences of the United States of America (1989)
Translational regulation of human p53 gene expression.
L. Fu;M. D. Minden;S. Benchimol.
The EMBO Journal (1996)
From telomere loss to p53 induction and activation of a DNA-damage pathway at senescence: the telomere loss/DNA damage model of cell aging.
Homayoun Vaziri;Sam Benchimol.
Experimental Gerontology (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Princess Margaret Cancer Centre
University of Manchester
Global HIV Vaccine Enterprise
Princess Margaret Cancer Centre
University Health Network
Structural Genomics Consortium
University of Toronto
Universidade de São Paulo
Princess Margaret Cancer Centre
University of Toronto
Harvard University
Fuzhou University
National Institutes of Health
Hawaii Agriculture Research Center
Freie Universität Berlin
University of California, Santa Barbara
Zoetis (United States)
Newcastle University
TU Wien
Harvard University
Luleå University of Technology
University of Arizona
Leiden University
University of Sydney
National Institutes of Health
Northern Illinois University